---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-093021"
form_type: "8-K"
ticker: "ORKA"
cik: "0000907654"
company_name: "Oruka Therapeutics, Inc."
filed_at: "2026-08-24T20:06:13+00:00"
generated_at: "2026-08-24T20:07:14.791483+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Oruka names Todd Edwards Chief Commercial Officer, eff. Aug 24 2026

## Summary
- Todd Edwards, ex-CCO of Arcutis Biotech, starts as Oruka's Chief Commercial Officer on Aug 24, 2026, reporting to CEO.
- Annual base salary $525,000; target bonus 40% of base; $200,000 signing bonus repayable prorated if resignation within 1 year.
- Equity grant: 20,000 options + 100,000 RSUs; options vest 25% at 1yr then monthly over 36mo, RSUs quarterly.
- Severance: 12 months base salary outside CIC; within CIC 1.0x (base+target) plus full acceleration of time-based equity.

## SEC filing metadata
- accession: 0001213900-26-093021
- form_type: 8-K
- ticker: ORKA
- cik: 0000907654
- company_name: Oruka Therapeutics, Inc.
- filed_at: 2026-08-24T20:06:13+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/907654/000121390026093021/0001213900-26-093021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/907654/000121390026093021/ea0302923-8k_oruka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-093021
- JSON: https://secwatch.observer/filing/0001213900-26-093021.json
- Plain text: https://secwatch.observer/filing/0001213900-26-093021.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.